| Literature DB >> 31437151 |
Nina Fuchsjäger1, Herwig Winterleitner1, Robert Krause2, Gebhard Feierl3, Horst Koch1.
Abstract
Hand infections are a common presentation at the emergency departments. Without knowing the source of infection clinicians are dependent on systematic reports on the bacterial spectrum and susceptibility tests of the specific infection in their patient community. This study was based on a retrospective chart review of patients presenting to our outpatient clinic with acute hand infections. We documented patient demographics, the etiology, location, culture tests of the infection and analyzed if certain bacteria could be cultured significantly more often in certain etiologies or in specific sites of the hand infection. Susceptibility tests were added. Bacterial swabs of 204 patients were analyzed. Overall S. aureus was found in 53% of all cases, in only one case revealed methicillin-resistant S. aureus (MRSA). There was no significant difference in the bacterial spectrum according to the etiology of the hand infections, except for animal bites where Pasteurella multocida was the dominating bacteria in 63% of all cases. Amoxicillin-clavulanic acid, fluoroquinolones, and piperacillin were effective against the main bacteria. Our study confirms the previously published antibiotic resistance reports and reinforces the current antibiotic treatment guidelines also in this western European population.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31437151 PMCID: PMC6705788 DOI: 10.1371/journal.pone.0220555
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of all specimens.
| Characteristics | No. isolated (% of specimen) |
|---|---|
| 204 | |
| 381 | |
| 1 (0.5) | |
| 108 (53) | |
| 41 (20) | |
| 54 (27) | |
| 142 (70) | |
| 21 (10) | |
| 40 (20) | |
| 129 (64) | |
| 1 (0.5) | |
| 73 (36) | |
| 381 | |
| 109 (53) | |
| 30 (15) | |
| 25 (12) | |
| 25 (12) | |
| 16 (8) | |
| 15 (7) | |
| 14 (7) | |
| 10 (5) | |
| 11 (5) | |
| 11 (5) | |
| 8 (4) | |
| 6 (3) | |
| 5 (2) | |
| 2 (1) | |
| 94 (25) |
Distribution and bacterial spectrum according to different aetiologies of hand infections.
| Total number of specimen n = 204 | Idiopathic | Trauma | Animal bites | Small lacerations | Retained foreign bodies | P-value | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| % | n | % | n | % | n | n | % | ||||
| 70 | 56 | 26 | 58 | 2 | 11 | 9 | 75 | 2 | 40 | <0.01 | |
| 21 | 17 | 5 | 11 | 2 | 11 | 1 | 8 | 1 | 20 | >0.1 | |
| 18 | 15 | 5 | 11 | 0 | 0 | 0 | 0 | 2 | 40 | 0.072 | |
| 12 | 10 | 3 | 7 | 0 | 0 | 1 | 8 | 0 | 0 | >0.1 | |
| 14 | 9 | 5 | 9 | 4 | 16 | 1 | 8 | 1 | 20 | >0.1 | |
| 8 | 7 | 2 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | >0.1 | |
| 2 | 2 | 1 | 2 | 12 | 63 | 0 | 0 | 0 | 0 | <0.01 | |
| 5 | 4 | 3 | 7 | 1 | 5 | 1 | 8 | 1 | 20 | >0.1 | |
| 3 | 2 | 1 | 2 | 0 | 0 | 1 | 8 | 0 | 0 | >0.1 | |
| 7 | 6 | 2 | 4 | 2 | 11 | 2 | 17 | 1 | 20 | >0.1 | |
| 4 | 3 | 1 | 2 | 1 | 5 | 0 | 0 | 0 | 0 | >0.1 | |
| 9 | 7 | 1 | 2 | 1 | 5 | 0 | 0 | 0 | 0 | >0.1 | |
| 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | >0.1 | |
| 7 | 6 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | >0.1 | |
a p-values were calculated using the Pearson’s chi-squared test.
Distribution and bacterial spectrum according to different localisations of hand infections.
| Total number of all specimen n = 204 | Infection in a subcutaneous plane n = 126, 62% | Paronychia | Infection of flexor tendon sheaths or flexor tendons n = 20, 10% | Dorsal abscesses and infection after extravasation | Not specified n = 7, 3% | P-value | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| % | % | % | % | % | |||||||
| 64 | 51 | 17 | 52 | 13 | 65 | 12 | 67 | 3 | 43 | >0.1 | |
| 14 | 11 | 8 | 24 | 4 | 20 | 2 | 11 | 2 | 29 | >0.1 | |
| 11 | 9 | 9 | 27 | 2 | 10 | 1 | 6 | 2 | 29 | 0.027 | |
| 11 | 9 | 2 | 6 | 1 | 5 | 1 | 6 | 1 | 14 | >0.1 | |
| 18 | 10 | 2 | 6 | 2 | 10 | 1 | 6 | 1 | 14 | >0.1 | |
| 8 | 6 | 1 | 3 | 1 | 5 | 0 | 0 | 0 | 0 | >0.1 | |
| 11 | 9 | 0 | 0 | 1 | 5 | 2 | 11 | 1 | 14 | >0.1 | |
| 7 | 5 | 3 | 9 | 0 | 0 | 1 | 6 | 0 | 0 | >0.1 | |
| 3 | 2 | 0 | 0 | 1 | 5 | 0 | 0 | 1 | 14 | >0.1 | |
| 7 | 6 | 5 | 15 | 1 | 5 | 0 | 0 | 1 | 14 | >0.1 | |
| 2 | 2 | 1 | 3 | 2 | 10 | 1 | 6 | 0 | 0 | >0.1 | |
| 8 | 6 | 2 | 6 | 1 | 5 | 0 | 0 | 0 | 0 | >0.1 | |
| 1 | 1 | 0 | 0 | 1 | 5 | 0 | 0 | 0 | 0 | >0.1 | |
| 6 | 5 | 1 | 3 | 0 | 0 | 0 | 0 | 1 | 14 | >0.1 | |
a p-values were calculated using the Pearson’s chi-squared test.
Susceptibility of most commonly found bacteria.
| Bacteria, % susceptible | |||||
|---|---|---|---|---|---|
| 23 | 100 | 100 | - | - | |
| 100 | - | - | - | - | |
| 23 | 100 | 100 | 0 | 100 | |
| 100 | 100 | 100 | 10 | 100 | |
| - | - | 100 | 100 | - | |
| 100 | 100 | 100 | 100 | - | |
| 100 | 100 | - | 0 | 100 | |
| 100 | 100 | 100 | 0 | 90 | |
| 100 | 100 | 100 | 0 | 100 | |
| - | - | 100 | 11 | - | |
| 100 | 100 | 100 | 100 | 100 | |
| - | - | 100 | 100 | - | |
| - | - | 100 | 100 | - | |
| 100 | 100 | 100 | - | - | |
| - | - | 100 | 100 | - | |
| 100 | 100 | 100 | 100 | - | |
| 97 | - | 100 | 100 | 100 | |
| 97 | - | - | 100 | - | |
| 94 | 35 | - | 100 | 90 | |
| 99 | 100 | 100 | 100 | - | |
| 100 | - | - | - | - | |
| 100 | 100 | - | 100 | 100 | |
| 100 | - | - | - | - | |
| 96 | 94 | - | - | 100 | |
| - | 100 | - | - | - | |
| - | 100 | - | - | - | |
| - | 100 | - | - | - | |
| 94 | 35 | - | 100 | 90 | |
| 100 | - | - | - | - | |
| 98 | 100 | - | - | - | |
| 100 | 100 | - | - | - | |
| 99 | 85 | 100 | 100 | 70 | |
| 100 | 100 | - | - | - | |
| 100 | 100 | - | - | - | |
| 99 | - | - | - | - | |
| 100 | - | - | - | 100 | |
| 100 | 100 | - | - | - | |
Pen, penicillin; Oxa, oxacillin; Amp, ampicillin; Amo, Amoxicillin-clavulanic acid; Mezl, mezlocillin; Pip, piperacilin; Cefac, cefaclor; Cefu, cefuroxime; Cefal, cefalexin; Cefoxit, cefoxitin; Cefotax, cefotaxime; Ceftazidi, ceftazidime; Cefepim, cefepime; Ceftr, ceftriaxone; Mero, meropenem; Imi, Imipenem; Gm, gentamicin; Tobra, tobramycine, Ami, amikacin; Cipr, ciprofloxacin; Mox; moxifloxacin; Oflo, ofloxacin; Levo, levofloxacin; Ery, erythromycin, Azit, azithromycin, Josa, josamycin; Clari, clarithromycin.
Tet, tetracycline; Mino, minocycline; Clind, clindamycin; Vanc, vancomycin; Sxt, trimethoprim-sulfamethoxazole; Fos, fosfomycine; Teico, teicoplanin; Fusi, fusidic acid; Rif, rifampicin, Lin, linezolid; -, not tested